Monika Baier

6.0k total citations · 1 hit paper
60 papers, 4.5k citations indexed

About

Monika Baier is a scholar working on Pathology and Forensic Medicine, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Monika Baier has authored 60 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pathology and Forensic Medicine, 16 papers in Oncology and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Monika Baier's work include Multiple Sclerosis Research Studies (19 papers), Colorectal Cancer Screening and Detection (4 papers) and Glaucoma and retinal disorders (4 papers). Monika Baier is often cited by papers focused on Multiple Sclerosis Research Studies (19 papers), Colorectal Cancer Screening and Detection (4 papers) and Glaucoma and retinal disorders (4 papers). Monika Baier collaborates with scholars based in United States, Germany and Switzerland. Monika Baier's co-authors include Gary Cutter, Bianca Weinstock‐Guttman, Richard A. Rudick, Fred Lublin, Michele Mass, Elizabeth Fisher, Steven Galetta, Nancy A. Simonian, Deborah Miller and Clyde Markowitz and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Monika Baier

60 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Relation of Visual Function to Retinal Nerve Fiber Layer Thickness in Multiple Sclerosis

2006 492 citations Dina Jacobs, Clyde Markowitz et al. Ophthalmology profile →

Peers

Countries citing papers authored by Monika Baier

Since Specialization

Citations

This map shows the geographic impact of Monika Baier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monika Baier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monika Baier more than expected).

Fields of papers citing papers by Monika Baier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monika Baier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monika Baier. The network helps show where Monika Baier may publish in the future.

Co-authorship network of co-authors of Monika Baier

This figure shows the co-authorship network connecting the top 25 collaborators of Monika Baier. A scholar is included among the top collaborators of Monika Baier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monika Baier. Monika Baier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Fast onset of action of glycopyrronium compared with tiotropium in patients with moderate to severe COPD — A randomised, multicentre, crossover trial 2016 ·Pulmonary Pharmacology & Therapeutics ·Henrik Watz, (unknown), Christoph May, Monika Baier, Anne‐Marie Kirsten	3
2	Effects of indacaterol/glycopyrronium (QVA149) on lung hyperinflation and physical activity in patients with moderate to severe COPD: a randomised, placebo-controlled, crossover study (The MOVE Study) 2016 ·BMC Pulmonary Medicine ·Henrik Watz, (unknown), Monika Baier, Anne Kirsten	35
3	Effect of adjuvant endocrine therapy on hormonal levels in premenopausal women with breast cancer: the ProBONE II study 2014 ·Breast Cancer Research and Treatment ·Peyman Hadji, (unknown), M. Ziller, Katrin Birkholz, Monika Baier, Mathias Muth, Peter Herbert Kann	12
4	Biomodulatory Treatment of Patients with Castration-Resistant Prostate Cancer: A Phase II Study of Imatinib with Pioglitazone, Etoricoxib, Dexamethasone and Low-Dose Treosulfan 2014 ·Cancer Microenvironment ·Martin Vogelhuber, Susan Feyerabend, Arnulf Stenzl, T. Suedhoff, Matthias B. Schulze, Jutta Huebner, R. Oberneder, W.F. Wieland, Stefan C. Mueller, Florian Eichhorn, Hans Heinzer, Katja Schmidt, Monika Baier, (unknown), Katrin Birkholz, (unknown), Reinhard Andreesen, W. Herr, Albrecht Reichle	12
5	Final Safety and Efficacy Analysis of a Phase I/II Trial with Imatinib and Vinorelbine for Patients with Metastatic Breast Cancer 2014 ·Oncology ·Nicolaì Maass, Christian Schem, Dirk Bauerschlag, Katharina Tiemann, (unknown), (unknown), Mathias Muth, Monika Baier, Marion T. Weigel, Antonia Wenners, İbrahim Alkatout, M. Bauer, W. Jonat, Christoph Mundhenke	12
6	Results from a 1-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral Deferasirox in patients diagnosed with low and int-1 risk myelodysplastic syndrome (MDS) and transfusion-dependent iron overload 2012 ·Annals of Hematology ·Florian Nolte, Britta Höchsmann, Aristoteles Giagounidis, Michael Lübbert, Uwe Platzbecker, Dagmar Haase, (unknown), Norbert Gattermann, Matthias Taupitz, Monika Baier, (unknown), (unknown), Christiane Schumann, W.‐K. Hofmann, Hubert Schrezenmeier	64
7	Randomised multicentre trial on safety and efficacy of rivastigmine in cognitively impaired multiple sclerosis patients 2012 ·Multiple Sclerosis Journal ·M. Mäurer, Sonja Ortler, Monika Baier, (unknown), P. Scherer, (unknown), Ferenc Tracik	21
8	Quality of life and health status with zoledronic acid and generic alendronate—a secondary analysis of the Rapid Onset and Sustained Efficacy (ROSE) study in postmenopausal women with low bone mass 2011 ·Osteoporosis International ·Peyman Hadji, Volker Ziller, (unknown), (unknown), (unknown), Monika Baier, (unknown), P. Kann	18
9	A randomized, rater-blinded, crossover study comparing the clinical efficacy of Ritalin® LA (methylphenidate) treatment in children with attention-deficit hyperactivity disorder under different breakfast conditions over 2 weeks 2010 ·ADHD Attention Deficit and Hyperactivity Disorders ·Eberhard Schulz, Christian Fleischhaker, Klaus Hennighausen, Philip Heiser, Frank Haessler, Martin Linder, (unknown), Andreas Warnke, Monika Baier, Jan Klatt	3
10	MHC-dependent desensitization of intrinsic anti-self reactivity 2008 ·Cancer Immunology Immunotherapy ·Cristan M. Jubala, (unknown), (unknown), Julie Lang, (unknown), David G. Coffey, Karen M. Helm, Jerome Schaack, Monika Baier, Gary Cutter, Donald Bellgrau, Jaime F. Modiano	6
11	Retinal nerve fiber layer thickness is associated with brain MRI outcomes in multiple sclerosis 2007 ·Journal of the Neurological Sciences ·Erica Grazioli, Robert Zivadinov, Bianca Weinstock‐Guttman, Norah S. Lincoff, Monika Baier, (unknown), Sara Hussein, Jennifer Cox, David Hojnacki, Murali Ramanathan	129
12	Relation of Visual Function to Retinal Nerve Fiber Layer Thickness in Multiple Sclerosis breakdown → 2006 ·Ophthalmology ·(unknown), Dina Jacobs, Clyde Markowitz, Steven Galetta, Nicholas J. Volpe, (unknown), Monika Baier, Elliot M. Frohman, Heather Winslow, Teresa C. Frohman	492
13	Low fat dietary intervention with ω-3 fatty acid supplementation in multiple sclerosis patients 2005 ·Prostaglandins Leukotrienes and Essential Fatty Acids ·Bianca Weinstock‐Guttman, Monika Baier, Youngmin Park, Joan Feichter, (unknown), Eileen Gallagher, Jaya T. Venkatraman, Kulwara Meksawan, (unknown), David Pendergast, Atif B. Awad, Murali Ramanathan, Frederick Munschauer, Richard A. Rudick	148
14	Genomic Effects of IFN-β in Multiple Sclerosis Patients 2003 ·The Journal of Immunology ·Bianca Weinstock‐Guttman, Darlene Badgett, Kara Patrick, (unknown), (unknown), (unknown), Monika Baier, Joan Feichter, Murali Ramanathan	94
15	Sex differences in in vitro pro-inflammatory cytokine production from peripheral blood of multiple sclerosis patients 2003 ·Journal of the Neurological Sciences ·Linh T. Nguyen, Murali Ramanathan, Bianca Weinstock‐Guttman, Monika Baier, Carol M. Brownscheidle, Lawrence Jacobs	57
16	Competing demands in the office visit: what influences mammography recommendations? 2002 ·PubMed ·Paul A. Nutting, Monika Baier, James J. Werner, Gary Cutter, Colleen Conry, Linda Stewart	89
17	Practice Patterns of Family Physicians in Practice-Based Research Networks: A Report From ASPN 1999 ·The Journal of the American Board of Family Medicine ·Paul A. Nutting, Monika Baier, James J. Werner, Gary Cutter, (unknown), A. John Orzano	33
18	Treatment of thyroid carcinoma in dogs by surgical resection alone: 20 cases (1981-1989) 1995 ·Journal of the American Veterinary Medical Association ·Mary K. Klein, Brian E. Powers, Stephen J. Withrow, Carey Curtis, (unknown), G K Ogilvie, (unknown), Mary F. Cooper, Monika Baier	45
19	Radiation therapy salvage of Hodgkin's disease following chemotherapy failure 1993 ·International Journal of Radiation OncologyBiologyPhysics ·Bryan R. Leigh, Keith A.A. Fox, (unknown), Monika Baier, (unknown), J. Robert Cassady	34
20	Segregation of color and form 1989 ·Die Naturwissenschaften ·R. Hilz, Ingo Rentschler, Monika Baier	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact